Package Leaflet: Information for the User
Sertraline Kern Pharma 100 mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine.
|
Contents of the pack:
Sertraline Kern Pharma contains sertraline as the active ingredient. Sertraline belongs to a group of medicines called selective serotonin reuptake inhibitors (SSRIs); these medicines are used to treat depression and/or anxiety disorders.
Sertraline Kern Pharma can be used to treat:
Depression is a clinical condition with symptoms such as feelings of sadness, inability to sleep well or enjoy life as you used to.
OCD and anxiety disorders are conditions related to anxiety, with symptoms such as being constantly worried about recurring ideas (obsessions) that lead to repetitive rituals (compulsions).
PTSD is a disorder that can occur after a highly traumatic emotional experience, and has some symptoms similar to depression and anxiety. Social anxiety disorder (social phobia) is an anxiety-related condition. It is characterized by intense anxiety or distress in social situations (e.g., talking to strangers, public speaking, eating or drinking in front of others, or worrying about behaving shamefully).
Your doctor has considered that this medicine is suitable for treating your condition.
If you are not sure why you have been prescribed Sertraline Kern Pharma, you should ask your doctor.
Do not take Sertraline Kern Pharma
Be cautious when taking Sertraline Kern Pharma
Medicines are not always suitable for everyone. Before starting treatment with Sertraline Kern Pharma, tell your doctor if you have or have had any of the following:
If you have had bleeding disorders or have been taking medicines that reduce blood clotting (such as aspirin, or warfarin) or that may increase the risk of bleeding, or if you are pregnant (see "Pregnancy").
Some medicines in the same group as Sertraline Kern Pharma (called SSRIs) may cause sexual dysfunction symptoms (see section 4). In some cases, these symptoms persist after stopping treatment.
Restlessness/Akathisia
The use of sertraline has been associated with akathisia (unpleasant feeling of restlessness and need to move, often accompanied by an inability to sit or stand still). This occurs more often during the first few weeks of treatment. Increasing the dose in patients who develop these symptoms may be harmful.
Withdrawal symptoms
When treatment is stopped, it is common for withdrawal symptoms to appear, particularly if treatment is stopped abruptly (see section 4, Possible side effects). The risk of experiencing withdrawal symptoms depends on the duration of treatment, the dose, and the rate at which the dose is reduced. Generally, these symptoms are mild or moderate. However, in some patients, they can be severe. These symptoms usually appear during the first few days after stopping treatment. In general, these symptoms usually resolve on their own and normally disappear within two weeks. In some patients, they can last longer (2-3 months or more). It is recommended that, when stopping treatment with sertraline, the dose should be gradually reduced over a period of several weeks or even months, according to the needs of each patient.
Thoughts of suicide and worsening of your depression or anxiety disorder
If you are depressed and/or have anxiety disorders, you may sometimes have thoughts of harming yourself or committing suicide. This may increase at the start of treatment with antidepressants, due to the fact that these medicines take time to work, which is usually a few weeks, but can sometimes be longer.
This is more likely to happen
If you have thoughts of harming yourself or committing suicide at any time, contact your doctor or go to the hospital immediately.
It may be helpful for you to tell a relative or close friend that you are depressed or have an anxiety disorder, and ask them to read this leaflet. You can also ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behavior.
Use in children and adolescents
Normally, sertraline should not be used in the treatment of children and adolescents under 18 years of age, except in the case of patients with obsessive-compulsive disorder. Patients under 18 years of age have a higher risk of adverse effects such as suicidal attempts, suicidal thoughts, and hostility (mainly aggression, confrontational behavior, and anger) when they are treated with this class of medicines. Nevertheless, it is possible that your doctor may decide to prescribe Sertraline Kern Pharma to a patient under 18 years of age if they consider it to be in the patient's best interests. If your doctor has prescribed Sertraline Kern Pharma to a patient under 18 years of age and you wish to discuss this decision, please contact your doctor. You should inform your doctor if any of the symptoms mentioned above appear or worsen when a patient under 18 years of age is taking sertraline.
At the same time, the long-term effects on safety and related to growth, maturity, and cognitive and behavioral development of sertraline in this age group have not yet been demonstrated.
Use of other medicines
Tell your doctor or pharmacist if you are using or have recently used any other medicines, including those obtained without a prescription.
Some medicines can affect the way Sertraline Kern Pharma works, or Sertraline Kern Pharma itself can reduce the effectiveness of other medicines that are being taken at the same time.
The use of Sertraline Kern Pharma with the following medicines can cause serious side effects
Tell your doctor if you are taking the following medicines
Taking Sertraline Kern Pharma with food and drinks
Sertraline Kern Pharma tablets can be taken with or without food.
Alcohol consumption should be avoided while being treated with sertraline.
Pregnancy and breastfeeding
Consult your doctor or pharmacist before using any medicine.
The safety of sertraline in pregnant women has not been fully established. Sertraline should only be administered to pregnant women if, in the doctor's judgment, the benefit to the mother outweighs any possible risk to the fetus. Women of childbearing age who are being treated with sertraline should use a suitable contraceptive method.
If you take Sertraline in the final stages of pregnancy, there may be an increased risk of heavy vaginal bleeding shortly after delivery, especially if you have a history of bleeding disorders. Your doctor or midwife should be aware that you are taking this medicine so that they can advise you.
There are indications that sertraline is excreted in breast milk. Therefore, sertraline can only be used in breastfeeding women if, in the doctor's judgment, the benefit to the mother outweighs any possible risk to the baby.
Driving and using machines
Antidepressant medicines like sertraline can affect your ability to drive or operate machinery. Therefore, do not drive or operate heavy machinery until you know how this medicine affects your ability to perform these activities.
Sertraline Kern Pharma contains lactose
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.
Follow the instructions for taking this medicine exactly as indicated by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.
Sertraline Kern Pharma tablets can be taken with or without food.
Take your medicine once a day, either in the morning or at night.
The recommended dose is:
Adults
Depression and Obsessive-Compulsive Disorder:
For depression and OCD, the effective dose is usually 50 mg per day. The daily dose can be increased in increments of 50 mg, at intervals of at least one week, over several weeks. The maximum recommended dose is 200 mg per day.
Panic Disorder, Social Anxiety Disorder, and Post-Traumatic Stress Disorder:
For panic disorder, social anxiety disorder, and PTSD, treatment should be started with a dose of 25 mg per day, and increased to 50 mg per day after one week.
The daily dose can be increased in increments of 50 mg over several weeks. The maximum recommended dose is 200 mg per day.
Children and adolescents
Sertraline Kern Pharma should only be used to treat children and adolescents aged 6 to 17 years with obsessive-compulsive disorder.
Obsessive-Compulsive Disorder:
Children aged 6 to 12 years:The recommended starting dose is 25 mg per day. After one week, your doctor may increase the dose to 50 mg per day. The maximum dose is 200 mg per day.
Adolescents aged 13 to 17 years:The recommended starting dose is 50 mg per day. The maximum dose is 200 mg per day.
If you have liver or kidney problems, inform your doctor and follow their instructions.
Your doctor will indicate the duration of treatment with this medicine. The duration will depend on the nature of your condition and your response to treatment. It will take several weeks before your symptoms start to improve.
If you take more Sertraline Kern Pharma than you should
If you accidentally take too much sertraline, contact your doctor or go to the emergency department of the nearest hospital. Always take the medicine packaging with you, whether it contains medicine or not.
You can also call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount taken.
Symptoms of overdose may include drowsiness, nausea, and vomiting, rapid heartbeat, tremors, agitation, dizziness, and in rare cases, loss of consciousness.
If you forget to take Sertraline Kern Pharma
If you forget to take a dose, do not take it when you remember. Take the next dose when it is due.
Do not take a double dose to make up for forgotten doses.
If you stop taking Sertraline Kern Pharma
Do not stop taking Sertraline Kern Pharma unless your doctor tells you to. Your doctor will want to gradually reduce the dose of Sertraline Kern Pharma over several weeks before you stop taking this medicine altogether. If you stop treatment abruptly, you may experience side effects such as dizziness, numbness, sleep disturbances, agitation, or anxiety, headaches, feeling unwell, or feeling dizzy and trembling. If you experience any of these side effects, or any other side effects during the discontinuation of your treatment with Sertraline Kern Pharma, please inform your doctor.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Sertralina Kern Pharma can cause adverse effects, although not all people suffer from them.
If you consider that any of the adverse effects you are experiencing is severe or if you notice any adverse effect not mentioned in this prospectus, inform your doctor or pharmacist.
The most common adverse effect is nausea. Adverse effects depend on the dose and often disappear when continuing treatment.
Inform your doctor immediately
If you experience any of the following symptoms after taking this medication, as these symptoms can be severe.
In rare cases, this syndrome can occur when taking certain medications at the same time as sertraline. Your doctor may decide to interrupt treatment.
The following adverse effects were observed in clinical trials in adults.
Very frequent adverse effects (occur in more than 1 patient out of 10):
Insomnia, dizziness, somnolence, headache, diarrhea, feeling of discomfort, dry mouth, ejaculation problems, and fatigue.
Frequent adverse effects (occur in between 1 and 10 out of 100 patients):
Sore throat, anorexia, increased appetite, depression, feeling strange, nightmares, anxiety, agitation, nervousness, decreased sexual interest, teeth grinding, numbness and tingling, tremor, muscle tension, abnormal taste, lack of concentration, visual disturbances, ringing in the ears, palpitations, hot flashes, yawning, abdominal pain, vomiting, constipation, stomach discomfort, gas, rash, increased sweating, muscle pain, sexual dysfunction, erectile dysfunction, and chest pain.
Infrequent adverse effects (occur in between 1 and 10 out of 1,000 patients):
Chest cold, runny nose, hallucinations, excessive happiness, lack of care, abnormal thoughts, convulsions, involuntary muscle contractions, abnormal coordination, continuous movements, amnesia, decreased sensitivity, speech disorders, dizziness when standing up, migraines, ear pain, rapid pulse, high blood pressure, hot flashes, breathing difficulties possibly noisy, shortness of breath, nasal bleeding, esophagus problems, difficulty swallowing, hemorrhoids, increased salivation, tongue alteration, belching, eye swelling, purple spots on the skin, hair loss, cold sweat, dry skin, hives, arthritis, muscle weakness, back pain, muscle spasms, need to urinate at night, urinary retention, increased urine volume, increased frequency of urination, urinary disorders, vaginal bleeding, female sexual dysfunction, discomfort, chills, fever, weakness, thirst, weight loss, and weight gain.
Rare adverse effects (occur in between 1 and 10 out of 10,000 patients):
Intestinal problems, ear infection, cancer, lymph node swelling, high cholesterol, elevated blood sugar, physical symptoms due to stress or emotions, drug dependence, psychotic disorders, aggression, paranoia, suicidal thoughts, sleepwalking, premature ejaculation, coma, abnormal movements, difficulty moving, increased sensitivity, sensory alterations, glaucoma, tear problems, appearance of spots in the visual field, double vision, eye damage from light, eye bleeding, irregular pupils, visual disturbances, tear problems.
Rare:vision of spots in front of the eyes, glaucoma, double vision, photophobia (eye sensitivity to light), eye bleeding, irregular pupils, visual disturbances, tear problems.
Frequency not known:partial loss of vision, colon inflammation (causing diarrhea), abundant vaginal bleeding shortly after childbirth (postpartum hemorrhage), see "Pregnancy" in section 2 for more information. Muscle weakness and intense muscle pain, which can be a sign of multiple acyl-CoA dehydrogenase deficiency (MADD).
Adverse effects in children and adolescents
In clinical trials in children and adolescents, adverse effects were generally similar to those reported in adults (see above). The most frequent adverse effects in children and adolescents were headache, insomnia, diarrhea, and nausea.
Reporting of adverse effects
If you experience any type of adverse effect, consult with your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Medicines Surveillance System for human use: www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep out of sight and reach of children.
Do not use Sertralina Kern Pharma after the expiration date that appears on the packaging after "CAD". The expiration date is the last day of the month indicated.
Store below 30°C.
Medicines should not be thrown away through the drains or into the trash. Deposit the packaging and medications you no longer need in the SIGRE Point of the pharmacy. Ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.
Composition of Sertralina Kern Pharma
Core of the tablet: anhydrous colloidal silica, microcrystalline cellulose (E-460i), sodium croscarmellose, copovidone, lactose monohydrate, and magnesium stearate (E-470b). Coating: hypromellose (E-464), hydroxypropylcellulose (E-463), titanium dioxide (E-171), and macrogol.
Appearance of the product and content of the packaging
Sertralina Kern Pharma 100 mg are film-coated tablets, white or almost white, with a capsule shape and scored. The tablets are presented in PVC/Aluminum blisters in packages containing 30 tablets.
Marketing authorization holder and manufacturer
Kern Pharma, S.L.
Venus, 72 - Pol. Ind. Colón II
08228 Terrassa - Barcelona
Spain
This prospectus was revised inJune 2025.
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.
The average price of SERTRALINE KERN PHARMA 100 mg FILM-COATED TABLETS in October, 2025 is around 11.66 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.